Literature DB >> 23766532

Estimating renal survival using the ANCA-associated GN classification.

Marc Hilhorst1, Benjamin Wilde, Peter van Breda Vriesman, Pieter van Paassen, Jan Willem Cohen Tervaert.   

Abstract

A histopathological classification system for ANCA-associated vasculitis was recently published, but whether this system predicts renal outcome requires validation. Here, we analyzed data from 164 consecutive patients with biopsy-proven renal involvement of ANCA-associated vasculitis. The ANCA-associated GN (AGN) classification categorizes patients as having focal, mixed, crescentic, or sclerotic GN. Five-year renal survival rates by categories of the AGN classification scheme were 91% for focal, 69% for mixed, and 64% for crescentic (log-rank P<0.0001). Only one patient was classified as sclerotic. Furthermore, the percentage of normal glomeruli found on biopsy estimated renal survival with the same precision as did the AGN classification scheme. Patients classified as crescentic or mixed, however, had worse survival when the percentage of normal glomeruli was <25%. In conclusion, the AGN classification for renal biopsy specimens is a practical and informative scheme with which to categorize patients with ANCA-associated vasculitis, but adding the percentage of normal glomeruli to the system seems to improve its predictive value.

Entities:  

Mesh:

Year:  2013        PMID: 23766532      PMCID: PMC3752945          DOI: 10.1681/ASN.2012090912

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  EULAR recommendations for the management of primary small and medium vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

2.  The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement.

Authors:  I M Bajema; E C Hagen; B E Hansen; J Hermans; L H Noël; R Waldherr; F Ferrario; F J van der Woude; J A Bruijn
Journal:  Nephrol Dial Transplant       Date:  1996-10       Impact factor: 5.992

Review 3.  ANCA small-vessel vasculitis.

Authors:  R J Falk; J C Jennette
Journal:  J Am Soc Nephrol       Date:  1997-02       Impact factor: 10.121

4.  Histopathologic classification of ANCA-associated glomerulonephritis.

Authors:  Annelies E Berden; Franco Ferrario; E Christiaan Hagen; David R Jayne; J Charles Jennette; Kensuke Joh; Irmgard Neumann; Laure-Hélène Noël; Charles D Pusey; Rüdiger Waldherr; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

5.  Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center.

Authors:  Dong-yuan Chang; Li-hua Wu; Gang Liu; Min Chen; Cees G M Kallenberg; Ming-hui Zhao
Journal:  Nephrol Dial Transplant       Date:  2011-11-25       Impact factor: 5.992

6.  Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy.

Authors:  Annelies E Berden; Rachel B Jones; Dianhdra D Erasmus; Michael Walsh; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; Jan A Bruijn; David R Jayne; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

7.  Epidemiology of idiopathic glomerular disease: a prospective study.

Authors:  A T Tiebosch; J Wolters; P F Frederik; T W van der Wiel; E Zeppenfeldt; P J van Breda Vriesman
Journal:  Kidney Int       Date:  1987-07       Impact factor: 10.612

8.  Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry.

Authors:  Pieter van Paassen; Peter J C van Breda Vriesman; Henk van Rie; Jan Willem Cohen Tervaert
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

9.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

10.  Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.

Authors:  Marjan C Slot; Jan Willem Cohen Tervaert; Casper F M Franssen; Coen A Stegeman
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

View more
  46 in total

1.  Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.

Authors:  Mazdak A Khalighi; Shihtien Wang; Kammi J Henriksen; Margret Bock; Mahima Keswani; Anthony Chang; Shane M Meehan
Journal:  Pediatr Nephrol       Date:  2015-02-12       Impact factor: 3.714

2.  Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.

Authors:  Yinghua Chen; Hao Bao; Zhengzhao Liu; Xia Liu; Erzhi Gao; Caihong Zeng; Haitao Zhang; Zhihong Liu; Weixin Hu
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

3.  Vasculitis: Validating the new classification system for ANCA-associated GN.

Authors:  Rebecca Kelsey
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

Review 4.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

5.  Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.

Authors:  XiaoWei Li; ShaoShan Liang; ChunXia Zheng; CaiHong Zeng; HaiTao Zhang; WeiXin Hu; ZhiHong Liu
Journal:  Pediatr Nephrol       Date:  2014-07-16       Impact factor: 3.714

Review 6.  Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.

Authors:  Lei Shi
Journal:  Rheumatol Int       Date:  2017-09-27       Impact factor: 2.631

7.  Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study.

Authors:  Rune Bjørneklett; Vilde Solbakken; Leif Bostad; Anne-Siri Fismen
Journal:  Int Urol Nephrol       Date:  2018-05-22       Impact factor: 2.370

8.  Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.

Authors:  Rune Bjørneklett; Sanjeevan Sriskandarajah; Leif Bostad
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 8.237

9.  Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.

Authors:  H Marco; J Draibe; J Villacorta; L F Quintana; N Martin; R Garcia-Osuna; C Cabre; M A Martín-Gómez; A Balius; A Saurina; M Picazo; I Gich-Saladich; M Navarro-Díaz; M Praga; T Cavero; J Ballarin; M M Díaz-Encarnación
Journal:  Clin Rheumatol       Date:  2018-03-09       Impact factor: 2.980

10.  Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.

Authors:  Daishi Hirano; Tomoaki Ishikawa; Aya Inaba; Mai Sato; Tomohiro Shinozaki; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2019-05-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.